AGE20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 21 LIGHT BEIGE
- Manufacturer
- Aekyung Industrial Co., Ltd.
- Effective date
- 2020-06-23
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 2
- Source
- legacy-cache
- Hydrated at
- 2026-08-01 23:24:45
Label at a glance#
ProductAGE20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 21 LIGHT BEIGE
Active ingredientOCTINOXATE, OCTOCRYLENE, TITANIUM DIOXIDE
Label structure1 sections
Label contents#
Full prescribing information#
Products#
Every source-derived product name is available through these pages.
- AGE20s SIGNATURE ESSENCE COVER PACT INTENSE COVER 21 LIGHT BEIGE
- Titanium Dioxide, Ethylhexyl Methoxycinnamate, Octocrylene
- ALPHA-TOCOPHEROL ACETATE
- CYCLOMETHICONE 6
- VINYLPYRROLIDONE/HEXADECENE COPOLYMER
- STEARIC ACID
- GLYCERYL CAPRYLATE
- GLYCERIN
- ADENOSINE
- POLYHYDROXYSTEARIC ACID STEARATE
- HYALURONIC ACID
- TRIETHOXYCAPRYLYLSILANE
- ALUMINUM OXIDE
- CHOLESTEROL
- BORON NITRIDE
- ASTAXANTHIN
- HYDROGENATED SOYBEAN LECITHIN
- FERROSOFERRIC OXIDE
- STEARYL HEPTANOATE
- MYRISTOYL/PALMITOYL OXOSTEARAMIDE/ARACHAMIDE MEA
- LINOLEIC ACID
- ALOE VERA LEAF
- BETULA PLATYPHYLLA VAR. JAPONICA RESIN
- BUTYLENE GLYCOL
- SQUALANE
- PROPANEDIOL
- DIMETHICONE
- CYCLOMETHICONE 5
- POLYMETHYLSILSESQUIOXANE (11 MICRONS)
- P-ANISIC ACID
- CANDELILLA WAX
- TRIISOSTEARIN
- 1,2-HEXANEDIOL
- DIPROPYLENE GLYCOL
- NIACINAMIDE
- MONOSODIUM GLUTAMATE
- BETULA PLATYPHYLLA BARK
- FERRIC OXIDE RED
- ALUMINUM HYDROXIDE
- C30-45 ALKYL METHICONE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 67225-6021 | 67225-6021-2 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| f765cbc9-e36f-f75c-e053-6294a90a679c | a2b066aa-c3a1-4b7e-e053-2a95a90a93da | 2023-03-21 | a2b066aa-c3a1-4b7e-e053-2a95a90a93da |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
